Shares of AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.25 and traded as high as $2.83. AIkido Pharma shares last traded at $2.71, with a volume of 11,031 shares trading hands.
AIkido Pharma Trading Down 1.8 %
The firm has a market cap of $14.86 million, a PE ratio of -0.70 and a beta of 0.93. The stock’s 50 day moving average price is $2.35 and its 200 day moving average price is $2.25.
AIkido Pharma Company Profile
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Read More
- Five stocks we like better than AIkido Pharma
- CD Calculator: Certificate of Deposit Calculator
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Basic Materials Stocks Investing
- Lockheed Martin Stock Aims for a Fresh All-Time High
- 3 Fintech Stocks With Good 2021 Prospects
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
